Literature DB >> 16204318

Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.

Arnaud Bonnefoy1, Kim Daenens, Hendrik B Feys, Rita De Vos, Petra Vandervoort, Jos Vermylen, Jack Lawler, Marc F Hoylaerts.   

Abstract

The function of thrombospondin-1 (TSP-1) in hemostasis was investigated in wild-type (WT) and Tsp1-/- mice, via dynamic platelet interaction studies with A23187-stimulated mesenteric endothelium and with photochemically injured cecum subendothelium. Injected calcein-labeled WT platelets tethered or firmly adhered to almost all A23187-stimulated blood vessels of WT mice, but Tsp1-/- platelets tethered to 45% and adhered to 25.8% of stimulated Tsp1-/- vessels only. Stimulation generated temporary endothelium-associated ultralarge von Willebrand factor (VWF) multimers, triggering platelet string formation in 48% of WT versus 20% of Tsp1-/- vessels. Injection of human TSP-1 or thrombotic thrombocytopenic purpura (TTP) patient-derived neutralizing anti-ADAMTS13 antibodies corrected the defective platelet recruitment in Tsp1-/- mice, while having a moderate effect in WT mice. Photochemical injury of intestinal blood vessels induced thrombotic occlusions with longer occlusion times in Tsp1-/- venules (1027 +/- 377 seconds) and arterioles (858 +/- 289 seconds) than in WT vessels (559 +/- 241 seconds, P < .001; 443 +/- 413 seconds, P < .003) due to defective thrombus adherence, resulting in embolization of complete thrombi, a defect restored by both human TSP-1 and anti-ADAMTS13 antibodies. We conclude that in a shear field, soluble or local platelet-released TSP-1 can protect unfolded endothelium-bound and subendothelial VWF from degradation by plasma ADAMTS13, thus securing platelet tethering and thrombus adherence to inflamed and injured endothelium, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204318      PMCID: PMC1895898          DOI: 10.1182/blood-2004-12-4856

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

Authors:  H Ni; C V Denis; S Subbarao; J L Degen; T N Sato; R O Hynes; D D Wagner
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  ADAMTS-13 metalloprotease interacts with the endothelial cell-derived ultra-large von Willebrand factor.

Authors:  Jing-fei Dong; Joel L Moake; Aubrey Bernardo; Kazuo Fujikawa; Chalmette Ball; Leticia Nolasco; José A López; Miguel A Cruz
Journal:  J Biol Chem       Date:  2003-05-29       Impact factor: 5.157

3.  Characterization of the binding of thrombospondin to human platelets and its association with the platelet cytoskeleton.

Authors:  V Dubernard; C Legrand
Journal:  J Lab Clin Med       Date:  1991-11

4.  Glycoproteins IIb and IIIa and platelet thrombospondin in a liposome model of platelet aggregation.

Authors:  M E Rybak
Journal:  Thromb Haemost       Date:  1986-04-30       Impact factor: 5.249

5.  Thrombspondin acts via integrin-associated protein to activate the platelet integrin alphaIIbbeta3.

Authors:  J Chung; A G Gao; W A Frazier
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

6.  An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin.

Authors:  J Lawler; R O Hynes
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

7.  A monoclonal antibody against human thrombospondin inhibits platelet aggregation.

Authors:  V M Dixit; D M Haverstick; K M O'Rourke; S W Hennessy; G A Grant; S A Santoro; W A Frazier
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Circulating activated platelets assist THP-1 monocytoid/endothelial cell interaction under shear stress.

Authors:  G Theilmeier; T Lenaerts; C Remacle; D Collen; J Vermylen; M F Hoylaerts
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

9.  Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics.

Authors:  K Vanschoonbeek; M A H Feijge; R J W Van Kampen; H Kenis; H C Hemker; P L A Giesen; J W M Heemskerk
Journal:  J Thromb Haemost       Date:  2004-03       Impact factor: 5.824

10.  P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface.

Authors:  Arnoldo Padilla; Joel L Moake; Aubrey Bernardo; Chalmette Ball; Yongtao Wang; Maneesh Arya; Leticia Nolasco; Nancy Turner; Michael C Berndt; Bahman Anvari; José A López; Jing-Fei Dong
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

View more
  55 in total

1.  Thrombospondin-1 Production Regulates the Inflammatory Cytokine Secretion in THP-1 Cells Through NF-κB Signaling Pathway.

Authors:  Tian Xing; Yao Wang; Wen-Jie Ding; Yuan-Ling Li; Xiao-Dong Hu; Cong Wang; Ao Ding; Ji-Long Shen
Journal:  Inflammation       Date:  2017-10       Impact factor: 4.092

Review 2.  ADAMTS13 and microvascular thrombosis.

Authors:  Han-Mou Tsai
Journal:  Expert Rev Cardiovasc Ther       Date:  2006-11

3.  Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease.

Authors:  Enrico M Novelli; Gregory J Kato; Mariana E Hildesheim; Suchitra Barge; Michael P Meyer; Jay Lozier; Andrea Cortese Hassett; Margaret V Ragni; Jeffrey S Isenberg; Mark T Gladwin
Journal:  Haematologica       Date:  2013-11       Impact factor: 9.941

4.  ADAMTS13 and its variants promote angiogenesis via upregulation of VEGF and VEGFR2.

Authors:  Manfai Lee; Justin Keener; Juan Xiao; X Long Zheng; George M Rodgers
Journal:  Cell Mol Life Sci       Date:  2014-06-21       Impact factor: 9.261

5.  The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis.

Authors:  Wolfgang Bergmeier; Crystal L Piffath; Tobias Goerge; Stephen M Cifuni; Zaverio M Ruggeri; Jerry Ware; Denisa D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

6.  Abnormal platelet function in C3-deficient mice.

Authors:  F C Gushiken; H Han; J Li; R E Rumbaut; V Afshar-Kharghan
Journal:  J Thromb Haemost       Date:  2009-03-05       Impact factor: 5.824

Review 7.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

8.  Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury.

Authors:  Claudio C Werneck; Cristina P Vicente; Justin S Weinberg; Adrian Shifren; Richard A Pierce; Thomas J Broekelmann; Douglas M Tollefsen; Robert P Mecham
Journal:  Blood       Date:  2008-02-15       Impact factor: 22.113

Review 9.  The kidney in thrombotic thrombocytopenic purpura.

Authors:  H-M Tsai
Journal:  Minerva Med       Date:  2007-12       Impact factor: 4.806

10.  Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis.

Authors:  Yves Decrem; Géraldine Rath; Virginie Blasioli; Philippe Cauchie; Séverine Robert; Jérôme Beaufays; Jean-Marie Frère; Olivier Feron; Jean-Michel Dogné; Chantal Dessy; Luc Vanhamme; Edmond Godfroid
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.